302 related articles for article (PubMed ID: 348066)
1. Bioavailability and pharmacokinetic analysis of drug responding systems.
Smolen VF
Annu Rev Pharmacol Toxicol; 1978; 18():495-522. PubMed ID: 348066
[No Abstract] [Full Text] [Related]
2. An overview of the analysis and interpretation of bioavailability studies in man.
Wagner JG
Arzneimittelforschung; 1976; 26(1A):105-8. PubMed ID: 947190
[TBL] [Abstract][Full Text] [Related]
3. Importance of biopharmaceutics and pharmacokinetics in clinical medicine.
Cabana BE
Arzneimittelforschung; 1976; 26(1A):151-8. PubMed ID: 947194
[TBL] [Abstract][Full Text] [Related]
4. [Bioavailability of drug products and bioequivalence requirements (author's transl)].
Jaminet F
J Pharm Belg; 1978; 33(3):141-56. PubMed ID: 682101
[No Abstract] [Full Text] [Related]
5. The potential clinical significance of differences in bioavailability.
Hosp Formul; 1976 Sep; 11(9):484, 487-8. PubMed ID: 10316482
[No Abstract] [Full Text] [Related]
6. [Pharmacology and practical therapy. Principles for the selection of application form of a drug and its mode of origin].
Levy G; Barr WH
Internist (Berl); 1973 Dec; 14(12):661-7. PubMed ID: 4593013
[No Abstract] [Full Text] [Related]
7. [Absorption and biological availability of drugs].
Uribe M
Rev Gastroenterol Mex; 1977; 42(1):2-8. PubMed ID: 616972
[TBL] [Abstract][Full Text] [Related]
8. [Methodological approach to the measure of the bioavailability of drugs in man (author's transl)].
Lesne M
J Pharm Belg; 1976; 31(1):5-24. PubMed ID: 768445
[No Abstract] [Full Text] [Related]
9. Biologic availability and therapeutic equivalence.
Arnold JD; Sicé J
J Clin Pharmacol; 1976 Oct; 16(10 Pt 2):546-9. PubMed ID: 977793
[No Abstract] [Full Text] [Related]
10. Bioavailability and bioequivalence.
Skelly JP
J Clin Pharmacol; 1976 Oct; 16(10 Pt 2):539-45. PubMed ID: 977792
[No Abstract] [Full Text] [Related]
11. [Biologic availability and "1st pass" effect of drugs].
Rietbrock N; Keller F
Fortschr Med; 1977 Jul; 95(28):1765-6, 1774-80. PubMed ID: 914146
[TBL] [Abstract][Full Text] [Related]
12. [Pharmacokinetic aspects relevant to biopharmaceutics].
Segre G
Ann Ist Super Sanita; 1982; 18(3):533-40. PubMed ID: 7187841
[No Abstract] [Full Text] [Related]
13. Bioavailability studies and the clinical pharmacologist: correlation of drug distribution with clinical effects.
Ogilvie RI
Int J Clin Pharmacol Biopharm; 1975 Jun; 11(4):349-54. PubMed ID: 1099026
[TBL] [Abstract][Full Text] [Related]
14. Bioavailability of drugs (second of two parts).
Koch-Weser J
N Engl J Med; 1974 Sep; 291(10):503-6. PubMed ID: 4604153
[No Abstract] [Full Text] [Related]
15. [Bioavailability and biopharmaceutics].
Colombo BM; Colombo MM; De Fusco R
Boll Chim Farm; 1976 Mar; 115(3):231-41. PubMed ID: 1275980
[No Abstract] [Full Text] [Related]
16. [Application of pharmacokinetics in clinical pharmacology and biopharmaceutics].
Xi NZ
Yao Xue Xue Bao; 1983 Feb; 18(2):151-60. PubMed ID: 6613595
[No Abstract] [Full Text] [Related]
17. Considerations for metabolite pharmacokinetic data in bioavailability/bioequivalence assessments. Overview of the recent trends.
Srinivas NR
Arzneimittelforschung; 2009; 59(4):155-65. PubMed ID: 19517891
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics and bioavailability.
Wagner JG
Triangle; 1975; 14(3-4):101-8. PubMed ID: 1209729
[No Abstract] [Full Text] [Related]
19. The significance of properly designed pre-clinical studies in the clinical evaluation of new drugs.
Garrett ER
Int Z Klin Pharmakol Ther Toxikol; 1970 Dec; 4(1):6-20. PubMed ID: 4924331
[No Abstract] [Full Text] [Related]
20. [The role of biopharmaceutical parameters in drug development (author's transl)].
Thoma K
Arzneimittelforschung; 1976; 26(1A):121-9. PubMed ID: 947191
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
